Compare Unichem Lab with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB GSK PHARMA UNICHEM LAB/
GSK PHARMA
 
P/E (TTM) x 89.0 68.1 130.6% View Chart
P/BV x 0.7 16.7 4.3% View Chart
Dividend Yield % 1.5 2.0 74.9%  

Financials

 UNICHEM LAB   GSK PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-21
GSK PHARMA
Mar-21
UNICHEM LAB/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs3601,805 19.9%   
Low Rs1221,155 10.5%   
Sales per share (Unadj.) Rs175.4188.8 92.9%  
Earnings per share (Unadj.) Rs4.921.1 23.3%  
Cash flow per share (Unadj.) Rs16.925.8 65.5%  
Dividends per share (Unadj.) Rs4.0030.00 13.3%  
Avg Dividend yield %1.72.0 81.9%  
Book value per share (Unadj.) Rs362.088.5 409.1%  
Shares outstanding (eoy) m70.41169.41 41.6%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.47.8 17.5%   
Avg P/E ratio x48.970.0 69.9%  
P/CF ratio (eoy) x14.257.3 24.9%  
Price / Book Value ratio x0.716.7 4.0%  
Dividend payout %81.2141.9 57.2%   
Avg Mkt Cap Rs m16,954250,695 6.8%   
No. of employees `000NANA-   
Total wages/salary Rs m3,0706,147 49.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,35131,989 38.6%  
Other income Rs m5021,106 45.4%   
Total revenues Rs m12,85333,094 38.8%   
Gross profit Rs m9115,227 17.4%  
Depreciation Rs m844793 106.4%   
Interest Rs m5135 145.0%   
Profit before tax Rs m5185,505 9.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1721,924 8.9%   
Profit after tax Rs m3473,581 9.7%  
Gross profit margin %7.416.3 45.1%  
Effective tax rate %33.134.9 94.7%   
Net profit margin %2.811.2 25.1%  
BALANCE SHEET DATA
Current assets Rs m13,77322,027 62.5%   
Current liabilities Rs m5,05813,325 38.0%   
Net working cap to sales %70.627.2 259.4%  
Current ratio x2.71.7 164.7%  
Inventory Days Days15547 330.3%  
Debtors Days Days740246 300.6%  
Net fixed assets Rs m17,3448,076 214.8%   
Share capital Rs m1411,694 8.3%   
"Free" reserves Rs m25,35013,297 190.6%   
Net worth Rs m25,49114,991 170.0%   
Long term debt Rs m00-   
Total assets Rs m31,11830,102 103.4%  
Interest coverage x11.1156.9 7.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.41.1 37.4%   
Return on assets %1.312.0 10.6%  
Return on equity %1.423.9 5.7%  
Return on capital %2.237.0 6.0%  
Exports to sales %82.80-   
Imports to sales %14.40.9 1,672.4%   
Exports (fob) Rs m10,224NA-   
Imports (cif) Rs m1,780276 645.7%   
Fx inflow Rs m10,224278 3,677.4%   
Fx outflow Rs m1,780276 645.7%   
Net fx Rs m8,4442 357,789.0%   
CASH FLOW
From Operations Rs m3315,779 5.7%  
From Investments Rs m-7364,186 -17.6%  
From Financial Activity Rs m-1,212-6,961 17.4%  
Net Cashflow Rs m-1,5413,004 -51.3%  

Share Holding

Indian Promoters % 50.9 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 10.6 12.6 84.6%  
FIIs % 1.5 1.7 89.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.1 25.0 196.3%  
Shareholders   33,892 121,445 27.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   BIOFIL CHEMICALS  AMRUTANJAN HEALTHCARE  SMRUTHI ORGANICS  CORAL LAB.  ALPA LAB  



Today's Market

Sensex Ends Above 61,000-Mark, Nifty Tops 18,300; Adani Ports, Wipro & Grasim Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks(Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Oct 14, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS